Overall survival from time of relapse after ASCT. (A) The Kaplan-Meier curves for overall survival from the time of posttransplantation relapse. The patients are grouped into 2-year intervals based on the date of relapse. (B) The Kaplan-Meier curves for the overall survival from the time of posttransplantation relapse grouped by whether they were treated subsequently with one or more of the newer drugs (thalidomide, bortezomib, or lenalidomide). Survival curves were compared using log-rank test.